本页面由Tiger Trade Technology Pte. Ltd.提供服务

Outlook Therapeutics, Inc.

0.5722
-0.0129-2.20%
成交量:227.16万
成交额:128.17万
市值:1.39亿
市盈率:-0.77
高:0.5812
开:0.5788
低:0.5510
收:0.5851
52周最高:2.54
52周最低:0.1611
股本:2.43亿
流通股本:1.98亿
量比:0.83
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-0.7479
每股收益(LYR):-1.7940
净资产收益率:-3.65%
总资产收益率:-143.17%
市净率:-13.38
市盈率(LYR):-0.32

数据加载中...

2024/04/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/03

SEC问询函

Form CORRESP - Correspondence
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/29

SEC问询函

Form CORRESP - Correspondence
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/01/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/24

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/12/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]